Medtronic PLC (NYSE: MDT) has reported earnings for its fourth fiscal quarter (ending April 30) of $0.49 versus $0.89 for the same period a year ago. For the latest four quarters through April 30, E.P.S. were $2.77 versus $2.83 for the same period a year ago.
Recent Price Action
Medtronic PLC (NYSE: MDT) stock suffered a large decline of -5.1% on 5/23/24. The stock closed at $81.38. Moreover, unusually high trading volume at 176% of normal accompanied the decline. The stock has performed in line with the market over the last nine months and has declined -3.9% during the last week.
Current PriceTarget Research Rating
MDT’s future returns on capital are forecasted to be above the cost of capital. Accordingly, the company is expected to continue to be a major Value Builder.
Medtronic has a current Value Trend Rating of C (Low Neutral). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing highly consistent signals. Medtronic has a neutral Power Rating of 49 and a neutral Appreciation Score of 41, and the Low Neutral Value Trend Rating results.
Rating Review
In light of this new information we are reviewing our current Overall Rating of C. This review will be completed in the next several days.
Be the first to comment